Codes / ICD10CM / T38.814S

T38.814S Poisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, sequela

Summary

This condition represents the residual effects or complications following poisoning by anterior pituitary hormones or their synthetic substitutes, where the intent of exposure was undetermined. It applies to sequelae (long-term consequences) resulting from the initial toxic event, capturing ongoing or chronic manifestations after the acute phase has resolved.

Causes

The causes relate to prior exposure to anterior pituitary hormones, their synthetic analogues, or antagonists, where the intent (e.g., accidental, intentional, or therapeutic error) was not clearly established. The sequela arises from the residual effects of the initial poisoning, which may involve tissue damage, metabolic imbalances, or persistent endocrine dysfunction.

Risk Factors

  • History of prior exposure to anterior pituitary hormones or substitutes
  • Underlying endocrine or metabolic disorders
  • Impaired organ function (e.g., renal, hepatic) affecting recovery
  • Inadequate follow-up after the initial poisoning event
  • Individual susceptibility to hormonal toxicity

Symptoms

Symptoms reflect the residual effects of the initial poisoning and may include chronic endocrine imbalances, organ dysfunction, or persistent metabolic disturbances. Manifestations depend on the specific hormone involved and the extent of tissue damage, potentially leading to long-term complications like hormone deficiency or excess.

Diagnosis

Diagnosis involves reviewing the patient’s history of prior poisoning by anterior pituitary hormones, clinical evaluation of residual symptoms, and relevant laboratory or imaging studies to assess ongoing effects. Documentation must confirm the sequela is directly related to the initial undetermined poisoning event.

Treatment Options

Treatment focuses on managing residual symptoms and preventing further complications. This may include hormone replacement therapy, monitoring of endocrine function, or interventions to address organ damage. Care is tailored to the specific sequelae and the patient’s overall health status.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the nature of the sequelae. Regular follow-up is essential to monitor for ongoing effects, adjust treatments, and address any new complications. Long-term management may be required for persistent endocrine or metabolic issues.

Complications

Potential complications include chronic endocrine dysfunction, organ damage, or metabolic disorders resulting from the initial poisoning. These may require ongoing medical intervention and impact quality of life.

Lifestyle & Prevention

Lifestyle modifications may support recovery, such as adhering to prescribed therapies, avoiding further exposure to hormonal agents, and maintaining regular medical check-ups. Prevention focuses on proper handling and storage of hormonal medications to reduce future risks.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms develop, such as severe fatigue, unexplained weight changes, or signs of organ dysfunction. Prompt evaluation is important to address complications and adjust treatment plans.

Tips for Medical Coders

Document the sequela clearly, linking it to the prior undetermined poisoning event. Ensure the code T38.814S is used only when the condition represents a residual effect of the initial poisoning. Verify that the intent of the original exposure was undetermined and that the sequela is directly attributable to the hormone-related toxicity.

Book a walkthrough

T38.814S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.